Home NDC 62135-019 Acyclovir
Product NDC 62135-019
11-digit product format 621350019
Labeler code 62135
Product ID 62135-019_458baf7d-dea5-aa22-e063-6394a90a8ae5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form TABLET
Route ORAL
Labeler Chartwell RX, LLC
Application ANDA210401
Marketing category ANDA
Marketing start 2018-05-04
Substance ACYCLOVIR
Active strength 800 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Acyclovir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 800 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197310, 197313
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62135-019-50 Acyclovir 50 in 1 BOTTLE TABLET 50 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62135-019 ACYCLOVIR CAPSULE ACYCLOVIR TABLET [CHARTWELL RX, LLC] 3 Current NDC, Legacy NDC, 1 package rows 20241012_8cd22728-34b4-4e55-8339-580138fe46d8.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62135-019-50 62135001950 50 TABLET in 1 BOTTLE (62135-019-50) 50 tablet 2022-07-01 0000-00-00 No No Current